Ondansetron HCL 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F73VR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,212
Award facts
- Contract value 100% obligated
- $12,212.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,212.41 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCl 8 mg tablets (30-count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The ondansetron tablets being delivered under this order are antiemetic medications commonly used in military and veteran healthcare settings. The company competes on a full and open basis for federal contracts, as evidenced by the non-set-aside designation of this award, and demonstrates extensive capability in fulfilling government requirements for essential pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F73VR?
SPE2DR26F73VR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F73VR worth?
The government has obligated $12,212 on SPE2DR26F73VR.
Is contract SPE2DR26F73VR an order under another contract?
Yes. SPE2DR26F73VR is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73VR competed?
The extent of competition for SPE2DR26F73VR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award